The Lymphoma Academic Research Organisation
Clinical trials sponsored by The Lymphoma Academic Research Organisation, explained in plain language.
-
New pill tested for Tough-to-Treat blood cancers
Disease control OngoingThis study is testing an oral medication called valemetostat for people with B-cell lymphoma that has come back or stopped responding to standard treatments. About 141 participants will take the pill daily to see if it shrinks their tumors and is safe. The goal is to control the …
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Apr 04, 2026 02:20 UTC
-
New drug combo trial aims to wipe out hidden cancer cells
Disease control OngoingThis study compares two different drug combinations for people newly diagnosed with mantle cell lymphoma, a type of blood cancer. It will test whether adding a drug called venetoclax to a standard treatment (ibrutinib plus an antibody) is more effective at eliminating traces of c…
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC